Oak Ridge Investments’s Mirum Pharmaceuticals MIRM Stock Holding History

Oak Ridge Investments’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.62M	Buy	22,408 +4,895	+28%	+$491K	0.15%	94
2026 Q1	$1.62M	Buy	17,513 +224	+1%	+$21.1K	0.11%	104
2025 Q4	$1.37M	Sell	17,289 -469	-3%	-$33.7K	0.08%	113
2025 Q3	$1.3M	Sell	17,758 -357	-2%	-$22.7K	0.08%	112
2025 Q2	$922K	Buy	+18,115	New	+$807K	0.07%	118

Other funds holding MIRM

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

SAM

Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

SOAM

SBI Okasan Asset Management Tokyo, Japan $3.04B AUM

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Oak Ridge Investments's MIRM Position: Q2 2026 in Review

Oak Ridge Investments increased its Mirum Pharmaceuticals (MIRM) stake by 28% in Q2 2026, buying an estimated $491K and bringing the position to 22,408 shares worth $2.62M. The position accounts for 0.15% of the portfolio, ranked #94.

Oak Ridge Investments first reported a position in MIRM in Q2 2025 and has held it in 5 quarters since. 45 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Oak Ridge Investments held 22,408 shares of Mirum Pharmaceuticals worth $2.62M as of Q2 2026.
Oak Ridge Investments bought 4,895 Mirum Pharmaceuticals shares in Q2 2026, an estimated $491K.
Mirum Pharmaceuticals made up 0.15% of Oak Ridge Investments's portfolio in Q2 2026, its #94 holding.
Oak Ridge Investments first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
45 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Oak Ridge Investments's 13F filing for Q2 2026, filed 21 Jul 2026.